Circulating hTERT mRNA as a tumor marker in cholangiocarcinoma patients

doi:10.3748/wjg.v12.i26.4195

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 26

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2401)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

251

HTML

1802

Figures (1-1)

192

Tables (1-3)

156

Sum=2401

Jul 14, 2006 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jul 14, 2006; 12(26): 4195-4198
Published online Jul 14, 2006. doi: 10.3748/wjg.v12.i26.4195

Open in New Tab Full Size Figure Download Figure

Figure 1 Continuously monitoring the development of signals in parallel standards and samples results in a series of amplification curves. The amplification of a 198 bp fragment of the generated hTERT cDNA was identified. (A: Signal from RMCCA1; B: Signal from HuCCA1; C, D: Signals from serum of cholangiocarcinoma patients; E, F: Signals from serum of benign biliary tract patients).

Citation: Leelawat K, Leelawat S, Ratanachu-Ek T, Trubwongchareon S, Wannaprasert J, Tripongkaruna S, Chantawibul S, Tepaksorn P. Circulating hTERT mRNA as a tumor marker in cholangiocarcinoma patients. World J Gastroenterol 2006; 12(26): 4195-4198
URL: https://www.wjgnet.com/1007-9327/full/v12/i26/4195.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i26.4195